Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 15 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 9890362

    Compositions, methods and uses for inducing viral growth

    Takeda Vaccines, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  2. US 9890213

    Methods for the treatment of B cell-mediated inflammatory diseases

    VACCINEX, INC. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  3. US 9884104

    Live attenuated virus vaccines for la crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  4. US 9885051

    Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

  5. US 9878031

    Compositions, methods of administration and uses for trivalent dengue virus formulations

    Takeda Vaccines, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  6. US 9867876

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  7. US 9861691

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  8. US 9834757

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  9. US 9828435

    Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency

    VACCINEX, INC. · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  10. US 9821049

    Method of conferring a protective immune response to Norovirus

    Takeda Vaccines, Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  11. US 9814771

    Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  12. US 9801934

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  13. US 9795662

    Vaccine comprising AMA1 and RON2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  14. US 9795665

    Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  15. US 9795661

    TH1/TH2 polarizing vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  16. US 9790271

    Methods for increasing immunoglobulin A levels

    VACCINEX, INC. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  17. US 9783579

    Compositions and methods for dengue virus chimeric constructs in vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  18. US 9783787

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  19. US 9770504

    Generating peptoid vaccines

    The Board of Regents of the University of Texas System · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  20. US 9758591

    Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  21. US 9750793

    Multifunctional oral vaccine based on chromosome recombineering

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  22. US 9713637

    Bacillus anthracis HtrA-defective-derived vaccines

    State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted

  23. US 9713638

    Compositions and methods for rapid immunization against dengue virus

    Takeda Vaccines, Inc. · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted

  24. US 9707289

    Biochemically stabilized HIV-1 ENV trimer vaccine

    NATIONAL INSTITUTES OF HEALTH (NIH), THE UNITED STATES OF AMERICA DEPT. OF HEALTH AND HUMAN SERVICES (DHHS). · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.